Psychedelics Optimi Health produces largest-ever batch of MDMA capsules The MDMA, psilocybin and functional mushroom producer also just scooped more funding Rowan DunneJanuary 29, 2025
Psychedelics Optimi Health gets psychedelics import permit for Mind Medicine Australia shipment BC's mushroom expert got an MDMA export permit for shipments to Israel this month too Rowan DunneMay 31, 2024
Psychedelics Optimi Health files U.S. patent for psilocybin extraction process The psychedelic drug developer says the new method increases potency while maintaining the mushroom's botanical qualities Rowan DunneAugust 1, 2023
News Optimi Health disputes allegations of failing $1.2M supply agreement The company announced the supply agreement last May Natalia Buendia CalvilloJuly 28, 2023
Psychedelics Optimi Health to supply MDMA for new psychedelic therapy program at Numinus clinics The experiential training will only be available through Numinus and will utilize the protocol of MAPS Rowan DunneJune 15, 2023
News Mind Medicine Australia to supply medical psilocybin and MDMA for clinical trials at no cost It is particularly interested in supporting research that optimizes treatment results and extends the application of psychedelic-assisted therapies Natalia Buendia CalvilloMay 18, 2023
News Optimi Health completes harvesting psilocybin mushrooms for Australia-bound medical extract Australia will allow psychiatrists to prescribe psilocybin and MDMA for certain conditions as of July 1 Natalia Buendia CalvilloMay 17, 2023
News Optimi Health obtains license to produce natural health products Natural products include probiotics, herbal remedies, vitamins and minerals, homeopathic medicines, traditional medicines among others Natalia Buendia CalvilloMay 10, 2023
Psychedelics Optimi Health enters $1.2M psilocybin distribution agreement The mushroom cultivator will be supplying a private client for clinical research purposes Rowan DunneMay 4, 2023
Psychedelics Optimi Health secures MDMA and psilocybin distribution agreement in Australia The company will supply Mind Medicine Australia with the substances, now considered designated therapies in the country Rowan DunneMarch 1, 2023